Lactoperoxidase

Last updated
LPO
Lactoperoxidase 2R5L.png
Identifiers
Aliases LPO , SPO, lactoperoxidase
External IDs OMIM: 150205 MGI: 1923363 HomoloGene: 21240 GeneCards: LPO
Orthologs
SpeciesHumanMouse
Entrez
Ensembl
UniProt
RefSeq (mRNA)

NM_001160102
NM_006151

NM_080420

RefSeq (protein)

NP_001153574
NP_006142

n/a

Location (UCSC) Chr 17: 58.22 – 58.27 Mb Chr 11: 87.7 – 87.72 Mb
PubMed search [3] [4]
Wikidata
View/Edit Human View/Edit Mouse

Lactoperoxidase is a peroxidase enzyme secreted from mammary, salivary and other mucosal glands including the lungs, bronchii and nose [5] that functions as a natural and the first line of defense against bacteria and viruses. [6] Lactoperoxidase is a member of the heme peroxidase family of enzymes. In humans, lactoperoxidase is encoded by the LPO gene. [7] [8]

Contents

Lactoperoxidase catalyzes the oxidation of several inorganic and organic substrates by hydrogen peroxide. [9] These substrates include bromide and iodide and therefore lactoperoxidase can be categorised as a haloperoxidase. An other important substrate is thiocyanate. The oxidized products produced through the action of this enzyme have potent and non-specific bactericidal and antiviral activities, including destruction of the influenza virus. Lactoperoxidase together with its inorganic ion substrates, hydrogen peroxide, and oxidized products is known as the lactoperoxidase system. [10] Hence LPO is considered a very important defense against invasive bacteria and viral agents such as influenza and the SARS-CoV-2 virus when sufficient iodine is provided. [11] [12] [13]

The lactoperoxidase system plays an important role in the innate immune system by killing bacteria in milk and mucosal (linings of mostly endodermal origin, covered in epithelium, which are involved in absorption and secretion) secretions hence augmentation of the lactoperoxidase system may have therapeutic applications. Furthermore, addition or augmentation of the lactoperoxidase system has potential applications in controlling bacteria in food and consumer health care products. The lactoperoxidase system does not attack DNA and is not mutagenic. [14] However, under certain conditions, the lactoperoxidase system may contribute to oxidative stress. [15] Furthermore, lactoperoxidase may contribute to the initiation of breast cancer, through its ability to oxidize estrogenic hormones producing free radical intermediates. [16]

Structure

The structure of lactoperoxidase consists mainly of alpha-helices plus two short antiparallel beta-strands. [17] Lactoperoxidase belongs to the heme peroxidase family of mammalian enzymes that also includes myeloperoxidase (MPO), eosinophil peroxidase (EPO), thyroid peroxidase (TPO), and prostaglandin H synthase (PGHS). A heme cofactor is bound near the center of the protein. [18]

Function

Lactoperoxidase catalyzes the hydrogen peroxide (H2O2) oxidation of several acceptor molecules: [19]

Specific examples include:

Source of the hydrogen peroxide (H2O2) usually is the reaction of glucose with oxygen in the presence of the enzyme glucose oxidase (EC 1.1.3.4) that also takes place in saliva. Glucose, in turn, can be formed from starch in the presence of the saliva enzyme amyloglucosidase (EC 3.2.1.3).

These relatively short lived oxidized intermediates have potent bactericidal effects, hence lactoperoxidase is part of the antimicrobial defense system in tissues that express lactoperoxidase. [10] The lactoperoxidase system is effective in killing a range of aerobic [22] and certain anaerobic microorganisms. [23] Research (1984): "The effect of lactoperoxidase-thiocyanate-hydrogen peroxide mixtures on bacteria is dependent on experimental conditions. If the bacteria are cultured after the exposure to lactoperoxidase-thiocyanate-hydrogen peroxide on nutrient agar under aerobic conditions, they may not grow, whereas they grow readily on blood agar under anaerobic conditions." [24] In its antimicrobial capacity, lactoperoxidase appears to acts synergistically with lactoferrin [25] and lysozyme. [26]

Applications

Lactoperoxidase is an effective antimicrobial and antiviral agent. Consequently, applications of lactoperoxidase are being found in preserving food, cosmetics, and ophthalmic solutions. Furthermore, lactoperoxidase have found application in dental and wound treatment. Finally lactoperoxidase may find application as anti-tumor and anti viral agents. [27] Lactoperoxidase has been used with radioactive iodine to selectively label membrane surfaces. [28]

Dairy products

Lactoperoxidase is an effective antimicrobial agent and is used as an antibacterial agent in reducing bacterial microflora in milk and milk products. [29] Activation of the lactoperoxidase system by addition of hydrogen peroxide and thiocyanate extends the shelf life of refrigerated raw milk. [19] [30] [31] [32] It is fairly heat resistant and is used as an indicator of overpasteurization of milk. [33]

Oral care

A lactoperoxidase system is claimed to appropriate for the treatment of gingivitis and paradentosis. [34] Lactoperoxidase has been used in toothpaste or a mouthrinse to reduce oral bacteria and consequently the acid produced by those bacteria. [35]

Cosmetics

A combination of lactoperoxidase, glucose, glucose oxidase (GOD), iodide and thiocyanate is claimed to be effective in the preservations of cosmetics. [36]

Cancer

Antibody conjugates of glucose oxidase and to lactoperoxidase have been found to effective in killing tumor cells in vitro. [37] In addition, macrophages exposed to lactoperoxidase are stimulated to kill cancer cells. [38] Knockout mice deficient in lactoperoxidase suffer ill-health and develop tumors. [39]

Clinical significance

Innate immune system

The antibacterial and anti-viral activities of lactoperoxidase play an important role in the mammalian immune defense system; the lactoperoxidase system is considered the first line of defense against airborne bacteria and viral agents. [40] [41] [42] Importantly, lactoperoxidase is also extruded into the lung, bronchii and nasal mucus. [43]

Hypothiocyanite is one of the reactive intermediates produced by the activity of lactoperoxidase on thiocyanate and hydrogen peroxide produced by dual oxidase 2 proteins, also known as Duox2. [44] [45] Thiocyanate secretion [46] in cystic fibrosis patients is decreased, resulting in a reduced production of the antimicrobial hypothiocyanite and consequently contributes to increased risk of airway infection. [47] [48]

Viral infections

Peroxidase-generated hypoiodous acid (HOI), hypoiodite and hypothiocyanite all destroy the herpes simplex virus [49] and human immunodeficiency virus. [50] Both the hypothiocyanite and the hypoiodate ion products are very potent and importantly non-specific antiviral oxidants which are lethal, even in small concentrations, to the influenza virus. [51] The anti-viral activity of lactoperoxidase is enhanced with increasing concentrations of iodide ion. [52] This enzyme has been shown effective against a highly dangerous and tough RNA virus (poliovirus) and a long-lived DNA virus (vaccina). [53]

Bacterial infections

The duox2-lactoperoxidase system has been shown to offer protection against many dozens of bacteria and mycoplasmas including varieties of the clinically important Staphylococcus and many Streptococcus types. [54] The lactoperoxidase system efficiently inhibits the common helicobacter pylori in buffer; however, in whole human saliva, it seems to have a weaker effect against this microbe. [55] It has been shown that lactoperoxidase in the presence of thiocyanide can catalyze the bactericidal and cytotoxic effects of hydrogen peroxide under specific conditions when hydrogen peroxide is present in excess of thiocyanide. [24] The combination of lactoperoxidase, hydrogen peroxide and thiocyanide is much more effective than hydrogen peroxide alone to inhibit bacterial metabolism and growth. [56]

Breast cancer

The oxidation of estradiol by lactoperoxidase is a possible source of oxidative stress in breast cancer. [15] [16] The ability of lactoperoxidase to propagate a chain reaction leading to oxygen consumption and intracellular hydrogen peroxide accumulation could explain the hydroxyl radical-induced DNA base lesions recently reported in female breast cancer tissue. [15] Lactoperoxidase may be involved in breast carcinogenesis, because of its ability to interact with estrogenic hormones and oxidise them through two one-electron reaction steps. [16] Lactoperoxidase reacts with the phenolic A-ring of estrogens to produce reactive free radicals. [57] In addition, lactoperoxidase may activate carcinogenic aromatic and heterocyclic amines and increase binding levels of activated products to DNA, which suggests a potential role of lactoperoxidase-catalyzed activation of carcinogens in the causation of breast cancer. [58]

Oral Care

During the last decades, several clinical studies describing the clinical efficacy of the lactoperoxidase system in a variety of oral care products (tooth pastes, mouth rinses) have been published. After showing indirectly, by means of measuring experimental gingivitis and caries parameters, that mouth rinses [59] [60] containing amyloglucosidase (γ-amylase) and glucose oxidase activate the lactoperoxidase system, the protective mechanism of the enzymes in oral care products has been partially elucidated. Enzymes such as lysozyme, lactoperoxidase and glucose oxidase are transferred from the tooth pastes to the pellicle. Being components of the pellicle, these enzymes are catalytically highly active. [61] [62] Also, as part of tooth pastes, the lactoperoxidase system has a beneficial influence to avoid early childhood caries [63] by reducing the number of colonies formed by the cariogenic microflora while increasing the thiocyanate concentration. With xerostomia patients, tooth pastes with the lactoperoxidase system are seemingly superior to fluoride-containing tooth pastes with respect to plaque formation and gingivitis. [64] More studies are required [62] to examine further the protective mechanisms. [65]

The application of lactoperoxidase is not restricted to caries, gingivitis, and periodontitis. [66] A combination of lysozyme and lactoperoxidase can be applied to support the treatment of the burning mouth syndrome (glossodynia). In combination with lactoferrin, lactoperoxidase combats halitosis; [67] in combination with lactoferrin and lysozyme, lactoperoxidase helps to improve symptoms of xerostomia. [68] Furthermore, gels with lactoperoxidase help to improve symptoms of oral cancer when saliva production is compromised due to irradiation. In this case, also the oral bacterial flora are influenced favorably. [69] [70] [71]

See also

Related Research Articles

<span class="mw-page-title-main">Mouthwash</span> Liquid rinse for oral hygiene

Mouthwash, mouth rinse, oral rinse, or mouth bath is a liquid which is held in the mouth passively or swirled around the mouth by contraction of the perioral muscles and/or movement of the head, and may be gargled, where the head is tilted back and the liquid bubbled at the back of the mouth.

<span class="mw-page-title-main">Catalase</span> Biocatalyst decomposing hydrogen peroxide

Catalase is a common enzyme found in nearly all living organisms exposed to oxygen which catalyzes the decomposition of hydrogen peroxide to water and oxygen. It is a very important enzyme in protecting the cell from oxidative damage by reactive oxygen species (ROS). Catalase has one of the highest turnover numbers of all enzymes; one catalase molecule can convert millions of hydrogen peroxide molecules to water and oxygen each second.

<span class="mw-page-title-main">Heme</span> Chemical coordination complex of an iron ion chelated to a porphyrin

Heme, or haem, is a precursor to hemoglobin, which is necessary to bind oxygen in the bloodstream. Heme is biosynthesized in both the bone marrow and the liver.

<span class="mw-page-title-main">Lactic acid</span> Group of stereoisomers

Lactic acid is an organic acid. It has a molecular formula CH3CH(OH)COOH. It is white in the solid state and it is miscible with water. When in the dissolved state, it forms a colorless solution. Production includes both artificial synthesis as well as natural sources. Lactic acid is an alpha-hydroxy acid (AHA) due to the presence of a hydroxyl group adjacent to the carboxyl group. It is used as a synthetic intermediate in many organic synthesis industries and in various biochemical industries. The conjugate base of lactic acid is called lactate. The name of the derived acyl group is lactoyl.

<span class="mw-page-title-main">Glutathione peroxidase</span> Enzyme family protecting the organism from oxidative damages

Glutathione peroxidase (GPx) is the general name of an enzyme family with peroxidase activity whose main biological role is to protect the organism from oxidative damage. The biochemical function of glutathione peroxidase is to reduce lipid hydroperoxides to their corresponding alcohols and to reduce free hydrogen peroxide to water.

<span class="mw-page-title-main">Saliva</span> Bodily fluid secreted by salivary glands

Saliva is an extracellular fluid produced and secreted by salivary glands in the mouth. In humans, saliva is around 99% water, plus electrolytes, mucus, white blood cells, epithelial cells, enzymes, antimicrobial agents.

<span class="mw-page-title-main">Cytochrome c peroxidase</span>

Cytochrome c peroxidase, or CCP, is a water-soluble heme-containing enzyme of the peroxidase family that takes reducing equivalents from cytochrome c and reduces hydrogen peroxide to water:

<span class="mw-page-title-main">Lactoferrin</span> Mammalian protein found in Homo sapiens

Lactoferrin (LF), also known as lactotransferrin (LTF), is a multifunctional protein of the transferrin family. Lactoferrin is a globular glycoprotein with a molecular mass of about 80 kDa that is widely represented in various secretory fluids, such as milk, saliva, tears, and nasal secretions. Lactoferrin is also present in secondary granules of PMNs and is secreted by some acinar cells. Lactoferrin can be purified from milk or produced recombinantly. Human colostrum has the highest concentration, followed by human milk, then cow milk (150 mg/L).

<span class="mw-page-title-main">Glucose oxidase</span> Class of enzymes

The glucose oxidase enzyme also known as notatin is an oxidoreductase that catalyses the oxidation of glucose to hydrogen peroxide and D-glucono-δ-lactone. This enzyme is produced by certain species of fungi and insects and displays antibacterial activity when oxygen and glucose are present.

<span class="mw-page-title-main">Thiocyanate</span> Ion (S=C=N, charge –1)

Thiocyanate is the anion [SCN], a salt or an ester of thiocyanic acid. It is the conjugate base of thiocyanic acid. Common derivatives include the colourless salts potassium thiocyanate and sodium thiocyanate. Mercury(II) thiocyanate was formerly used in pyrotechnics.

<i>Streptococcus mutans</i> Species of bacterium

Streptococcus mutans is a facultatively anaerobic, gram-positive coccus commonly found in the human oral cavity and is a significant contributor to tooth decay. It is part of the "streptococci", an informal general name for all species in the genus Streptococcus. The microbe was first described by James Kilian Clarke in 1924.

Iron-binding proteins are carrier proteins and metalloproteins that are important in iron metabolism and the immune response. Iron is required for life.

<span class="mw-page-title-main">Animal heme-dependent peroxidases</span>

Animal heme-dependent peroxidases is a family of peroxidases. Peroxidases are found in bacteria, fungi, plants and animals. On the basis of sequence similarity, a number of animal heme peroxidases can be categorized as members of a superfamily: myeloperoxidase (MPO); eosinophil peroxidase (EPO); lactoperoxidase (LPO); thyroid peroxidase (TPO); prostaglandin H synthase (PGHS); and peroxidasin.

Haloperoxidases are peroxidases that are able to mediate the oxidation of halides by hydrogen peroxide. Both halides and hydrogen peroxide are widely available in the environment.

Biotene is an over-the-counter dental hygiene product currently marketed by GlaxoSmithKline (GSK). It comes in a number of forms, including toothpaste, mouthwash and gel.

Hypothiocyanite is the anion [OSCN] and the conjugate base of hypothiocyanous acid (HOSCN). It is an organic compound part of the thiocyanates as it contains the functional group SCN. It is formed when an oxygen is singly bonded to the thiocyanate group. Hypothiocyanous acid is a fairly weak acid; its acid dissociation constant (pKa) is 5.3.

The respiratory tract antimicrobial defense system is a layered defense mechanism which relies on components of both the innate and adaptive immune systems to protect the lungs and the rest of the respiratory tract against inhaled microorganisms.

Haem peroxidases (or heme peroxidases) are haem-containing enzymes that use hydrogen peroxide as the electron acceptor to catalyse a number of oxidative reactions. Most haem peroxidases follow the reaction scheme:

<span class="mw-page-title-main">Eosinophil peroxidase</span> Protein-coding gene in the species Homo sapiens

Eosinophil peroxidase is an enzyme found within the eosinophil granulocytes, innate immune cells of humans and mammals. This oxidoreductase protein is encoded by the gene EPX, expressed within these myeloid cells. EPO shares many similarities with its orthologous peroxidases, myeloperoxidase (MPO), lactoperoxidase (LPO), and thyroid peroxidase (TPO). The protein is concentrated in secretory granules within eosinophils. Eosinophil peroxidase is a heme peroxidase, its activities including the oxidation of halide ions to bacteriocidal reactive oxygen species, the cationic disruption of bacterial cell walls, and the post-translational modification of protein amino acid residues.

<span class="mw-page-title-main">Sujata Sharma</span> Indian biophysicist

Sujata Sharma is an Indian structural biologist, biophysicist, writer and a professor at the Department of Biophysics of the All India Institute of Medical Sciences, Delhi. She is known for her studies in the fields of protein structure, drug design and drug resistance of bacteria. Her studies have been documented by way of a number of articles and ResearchGate, an online repository of scientific articles has listed 167 of them. She is also the author of the books, "Warriors in White", an autobiographical account of some COVID-19 Warriors at All India Institute of Medical Sciences, Delhi and other leading hospitals of India, including Prof Randeep Guleria, using a combination of modern medicine, astronomy and Vedic astrology, "The Secret of the Red Crystals", an autobiographical account of her days in AIIMS Delhi. and "A Dragonfly's purpose", which is an autobiographical account of her recovery from an autoimmune disease, Guillain Barre Syndrome. The Department of Biotechnology of the Government of India awarded her the National Bioscience Award for Career Development, one of the highest Indian science awards, for her contributions to biosciences, in 2011. She is also a recipient of the Woman Scientist Award of the Biotech Research Society of India and the National Young Woman Bioscientist Award of the Department of Biotechnology which she received in 2006 and 2007 respectively. In 2020, she was awarded the Kalpana Chawla Excellence award, for her contributions in science. This award is instituted in the memory of the first Indian woman astronaut, Kalpana Chawla to go on space missions.

References

  1. 1 2 3 GRCh38: Ensembl release 89: ENSG00000167419 - Ensembl, May 2017
  2. 1 2 3 GRCm38: Ensembl release 89: ENSMUSG00000009356 - Ensembl, May 2017
  3. "Human PubMed Reference:". National Center for Biotechnology Information, U.S. National Library of Medicine.
  4. "Mouse PubMed Reference:". National Center for Biotechnology Information, U.S. National Library of Medicine.
  5. Tenovuo JO (1985). "The peroxidase system in human secretions". In Tenovuo JO, Pruitt KM (eds.). The Lactoperoxidase system: chemistry and biological significance. New York: Dekker. p. 272. ISBN   978-0-8247-7298-7.
  6. Pruitt KM, Reiter B (1985). "Biochemistry of peroxidase systems: antimicrobial effects". In Tenovuo JO, Pruitt KM (eds.). The Lactoperoxidase system: chemistry and biological significance. New York: Dekker. p. 272. ISBN   978-0-8247-7298-7.
  7. Dull TJ, Uyeda C, Strosberg AD, Nedwin G, Seilhamer JJ (September 1990). "Molecular cloning of cDNAs encoding bovine and human lactoperoxidase". DNA and Cell Biology. 9 (7): 499–509. doi:10.1089/dna.1990.9.499. PMID   2222811.
  8. Kiser C, Caterina CK, Engler JA, Rahemtulla B, Rahemtulla F (September 1996). "Cloning and sequence analysis of the human salivary peroxidase-encoding cDNA". Gene. 173 (2): 261–4. doi:10.1016/0378-1119(96)00078-9. PMID   8964511.
  9. Kohler H, Jenzer H (1989). "Interaction of lactoperoxidase with hydrogen peroxide. Formation of enzyme intermediates and generation of free radicals". Free Radical Biology & Medicine. 6 (3): 323–39. doi:10.1016/0891-5849(89)90059-2. PMID   2545551.
  10. 1 2 Tenovuo JO, Pruitt KM, eds. (1985). The Lactoperoxidase system: chemistry and biological significance. New York: Dekker. p. 272. ISBN   978-0-8247-7298-7.
  11. Rayman MP (November 2020). "Iodine and Selenium as Antiviral Agents: Potential Relevance to SARS-CoV-2 and Covid-19". Archives of Oral and Maxillofacial Surgery. 3 (1): 69. doi: 10.36959/379/357 . ISSN   2689-8772.
  12. Derscheid RJ, van Geelen A, Berkebile AR, Gallup JM, Hostetter SJ, Banfi B, et al. (February 2014). "Increased concentration of iodide in airway secretions is associated with reduced respiratory syncytial virus disease severity". American Journal of Respiratory Cell and Molecular Biology. 50 (2): 389–97. doi:10.1165/rcmb.2012-0529OC. PMC   3930944 . PMID   24053146.
  13. Smith ML, Sharma S, Singh TP (September 2021). "Iodide supplementation of the anti-viral duox-lactoperoxidase activity may prevent some SARS-CoV-2 infections". European Journal of Clinical Nutrition. 76 (4): 629–630. doi:10.1038/s41430-021-00995-2. PMC   8408568 . PMID   34471253.
  14. White WE, Pruitt KM, Mansson-Rahemtulla B (February 1983). "Peroxidase-thiocyanate-peroxide antibacterial system does not damage DNA". Antimicrobial Agents and Chemotherapy. 23 (2): 267–72. doi:10.1128/aac.23.2.267. PMC   186035 . PMID   6340603.
  15. 1 2 3 Sipe HJ, Jordan SJ, Hanna PM, Mason RP (November 1994). "The metabolism of 17 beta-estradiol by lactoperoxidase: a possible source of oxidative stress in breast cancer". Carcinogenesis. 15 (11): 2637–43. doi:10.1093/carcin/15.11.2637. PMID   7955118.
  16. 1 2 3 Ghibaudi EM, Laurenti E, Beltramo P, Ferrari RP (2000). "Can estrogenic radicals, generated by lactoperoxidase, be involved in the molecular mechanism of breast carcinogenesis?". Redox Report. 5 (4): 229–35. doi: 10.1179/135100000101535672 . PMID   10994878. S2CID   24253204.
  17. Singh AK, Smith ML, Yamini S, Ohlsson PI, Sinha M, Kaur P, et al. (October 2012). "Bovine carbonyl lactoperoxidase structure at 2.0Å resolution and infrared spectra as a function of pH". The Protein Journal. 31 (7): 598–608. doi:10.1007/s10930-012-9436-3. PMID   22886082. S2CID   22945713.
  18. PDB: 2r5l ; Singh AK, Singh N, Sharma S, Singh SB, Kaur P, Bhushan A, et al. (February 2008). "Crystal structure of lactoperoxidase at 2.4 A resolution". Journal of Molecular Biology. 376 (4): 1060–75. doi:10.1016/j.jmb.2007.12.012. PMID   18191143.
  19. 1 2 de Wit JN, van Hooydonk AC (1996). "Structure, functions and applications of lactoperoxidase in natural antimicrobial systems". Netherlands Milk & Dairy Journal. 50: 227–244.
  20. Wever R, Kast WM, Kasinoedin JH, Boelens R (December 1982). "The peroxidation of thiocyanate catalysed by myeloperoxidase and lactoperoxidase". Biochimica et Biophysica Acta (BBA) - Protein Structure and Molecular Enzymology. 709 (2): 212–9. doi:10.1016/0167-4838(82)90463-0. PMID   6295491.
  21. Pruitt KM, Tenovuo J, Andrews RW, McKane T (February 1982). "Lactoperoxidase-catalyzed oxidation of thiocyanate: polarographic study of the oxidation products". Biochemistry. 21 (3): 562–7. doi:10.1021/bi00532a023. PMID   7066307.
  22. Fweja LW, Lewis MJ, Grandison AS (July 2008). "Challenge testing the lactoperoxidase system against a range of bacteria using different activation agents". Journal of Dairy Science. 91 (7): 2566–74. doi: 10.3168/jds.2007-0322 . PMID   18565914.
  23. Courtois P, Majerus P, Labbé M, Vanden Abbeele A, Yourassowsky E, Pourtois M (September 1992). "Susceptibility of anaerobic microorganisms to hypothiocyanite produced by lactoperoxidase". Acta Stomatologica Belgica. 89 (3): 155–62. PMID   1481764.
  24. 1 2 Carlsson J, Edlund MB, Hänström L (June 1984). "Bactericidal and cytotoxic effects of hypothiocyanite-hydrogen peroxide mixtures". Infection and Immunity. 44 (3): 581–6. doi:10.1128/IAI.44.3.581-586.1984. PMC   263633 . PMID   6724690.
  25. Reiter B (1983). "The biological significance of lactoferrin". International Journal of Tissue Reactions. 5 (1): 87–96. PMID   6345430.
  26. Roger V, Tenovuo J, Lenander-Lumikari M, Söderling E, Vilja P (1994). "Lysozyme and lactoperoxidase inhibit the adherence of Streptococcus mutans NCTC 10449 (serotype c) to saliva-treated hydroxyapatite in vitro". Caries Research. 28 (6): 421–8. doi:10.1159/000262015. PMID   7850845.
  27. Harper WJ (2000). Biological properties of whey components a review. Chicago, IL: American Dairy Products Institute. p. 54.
  28. Poduslo JF, Braun PE (February 1975). "Topographical arrangement of membrane proteins in the intact myelin sheath. Lactoperoxidase incorproation of iodine into myelin surface proteins". The Journal of Biological Chemistry. 250 (3): 1099–105. doi: 10.1016/S0021-9258(19)41895-4 . PMID   1112791.
  29. Reiter B.; Härnulv BG. "The preservation of refrigerated and uncooled milk by its natural lactoperoxidase system". Dairy Ind. Int. 47 (5): 13–19.
  30. Zajac M, Glandys J, Skarzynska M, Härnulv G, Eilertsen K (1983). "Milk quality preservation by heat treatment or activation of the lactoperoxidase system in combination with refrigerated storage". Milchwissenschaft. 38 (11).
  31. Zajac M, Gladys J, Skarzynska M, Härnulv G, Björck L (December 1983). "Changes in Bacteriological Quality of Raw Milk Stabilized by Activation of its Lactoperoxidase System and Stored at Different Temperatures". Journal of Food Protection. 46 (12): 1065–1068. doi: 10.4315/0362-028x-46.12.1065 . PMID   30921865.
  32. Korhonen H (1980). "A new method for preserving raw milk: The lactoperoxidase antibacterial system". World Anim. Rev. 35: 23–29.
  33. Marks NE, Grandison AS, Lewis MJ (2008). "Use of hydrogen peroxide detection strips to determine the extent of pasteurization in whole milk". International Journal of Dairy Technology. 54 (1): 20–22. doi:10.1046/j.1471-0307.2001.00008.x.
  34. WOapplication WO1988002600,Poulson OM,"Enzyme-containing bactericidal composition, and dental and wound treatment preparations comprising this composition",published 1988-04-21
  35. Hoogedoorn H (1985). "Activation of the salivary peroxidase system: clinical studies". In Tenovuo JO, Pruitt KM (eds.). The Lactoperoxidase system: chemistry and biological significance. New York: Dekker. pp. 217–228. ISBN   978-0-8247-7298-7.
  36. US 5607681,Galley E, Godfrey DC, Guthrie WG, Hodgkinson DM, Linnington HL,"Antimicrobial Compositions Containing Iodide, Thiocyanate, Glucose And Glucose Oxidase",published 1997-03-04, assigned to The Boots Company PLC
  37. Stanislawski M, Rousseau V, Goavec M, Ito H (October 1989). "Immunotoxins containing glucose oxidase and lactoperoxidase with tumoricidal properties: in vitro killing effectiveness in a mouse plasmacytoma cell model". Cancer Research. 49 (20): 5497–504. PMID   2790777.
  38. Lefkowitz DL, Hsieh TC, Mills K, Castro A (1990). "Induction of tumor necrosis factor and cytotoxicity by macrophages exposed to lactoperoxidase and microperoxidase". Life Sciences. 47 (8): 703–9. doi:10.1016/0024-3205(90)90625-2. PMID   2402192.
  39. Yamakaze J, Lu, Z (2021). "Deletion of the lactoperoxidase gene causes multisystem inflammation and tumors in mice". Scientific Reports. 11 (1): 12429. doi:10.1038/s41598-021-91745-8. PMC   8203638 . PMID   34127712.
  40. Wijkstrom-Frei C, El-Chemaly S, Ali-Rachedi R, Gerson C, Cobas MA, Forteza R, et al. (August 2003). "Lactoperoxidase and human airway host defense". American Journal of Respiratory Cell and Molecular Biology. 29 (2): 206–12. CiteSeerX   10.1.1.325.1962 . doi:10.1165/rcmb.2002-0152OC. PMID   12626341.
  41. Conner GE, Salathe M, Forteza R (December 2002). "Lactoperoxidase and hydrogen peroxide metabolism in the airway". American Journal of Respiratory and Critical Care Medicine. 166 (12 Pt 2): S57-61. doi:10.1164/rccm.2206018. PMID   12471090.
  42. Conner GE, Wijkstrom-Frei C, Randell SH, Fernandez VE, Salathe M (January 2007). "The lactoperoxidase system links anion transport to host defense in cystic fibrosis". FEBS Letters. 581 (2): 271–8. doi:10.1016/j.febslet.2006.12.025. PMC   1851694 . PMID   17204267.
  43. Sharma S, Singh AK, Kaushik S, Sinha M, Singh RP, Sharma P, et al. (September 2013). "Lactoperoxidase: structural insights into the function,ligand binding and inhibition". International Journal of Biochemistry and Molecular Biology. 4 (3): 108–28. PMC   3776144 . PMID   24049667.
  44. Thomas EL, Bates KP, Jefferson MM (September 1980). "Hypothiocyanite ion: detection of the antimicrobial agent in human saliva". Journal of Dental Research. 59 (9): 1466–72. doi:10.1177/00220345800590090201. PMID   6931123. S2CID   7717994.
  45. Thomas EL, Aune TM (May 1978). "Lactoperoxidase, peroxide, thiocyanate antimicrobial system: correlation of sulfhydryl oxidation with antimicrobial action". Infection and Immunity. 20 (2): 456–63. doi:10.1128/IAI.20.2.456-463.1978. PMC   421877 . PMID   352945.
  46. Xu Y, Szép S, Lu Z (December 2009). "The antioxidant role of thiocyanate in the pathogenesis of cystic fibrosis and other inflammation-related diseases". Proceedings of the National Academy of Sciences of the United States of America. 106 (48): 20515–9. Bibcode:2009PNAS..10620515X. doi: 10.1073/pnas.0911412106 . PMC   2777967 . PMID   19918082.
  47. Moskwa P, Lorentzen D, Excoffon KJ, Zabner J, McCray PB, Nauseef WM, et al. (January 2007). "A novel host defense system of airways is defective in cystic fibrosis". American Journal of Respiratory and Critical Care Medicine. 175 (2): 174–83. doi:10.1164/rccm.200607-1029OC. PMC   2720149 . PMID   17082494.
  48. Minarowski Ł, Sands D, Minarowska A, Karwowska A, Sulewska A, Gacko M, Chyczewska E (2008). "Thiocyanate concentration in saliva of cystic fibrosis patients". Folia Histochemica et Cytobiologica. 46 (2): 245–6. doi: 10.2478/v10042-008-0037-0 . PMID   18519245.
  49. Mikola H, Waris M, Tenovuo J (March 1995). "Inhibition of herpes simplex virus type 1, respiratory syncytial virus and echovirus type 11 by peroxidase-generated hypothiocyanite". Antiviral Research. 26 (2): 161–71. doi:10.1016/0166-3542(94)00073-H. PMID   7605114.
  50. Pourtois M, Binet C, Van Tieghem N, Courtois PR, Vandenabbeele A, Thirty L (May 1991). "Saliva can contribute in quick inhibition of HIV infectivity". AIDS. 5 (5): 598–600. doi:10.1097/00002030-199105000-00022. PMID   1650564.
  51. Patel U, Gingerich A, Widman L, Sarr D, Tripp RA, Rada B (2018). "Susceptibility of influenza viruses to hypothiocyanite and hypoiodite produced by lactoperoxidase in a cell-free system". PLOS ONE. 13 (7): e0199167. Bibcode:2018PLoSO..1399167P. doi: 10.1371/journal.pone.0199167 . PMC   6059396 . PMID   30044776.
  52. Fischer AJ, Lennemann NJ, Krishnamurthy S, Pócza P, Durairaj L, Launspach JL, et al. (October 2011). "Enhancement of respiratory mucosal antiviral defenses by the oxidation of iodide". American Journal of Respiratory Cell and Molecular Biology. 45 (4): 874–81. doi:10.1165/rcmb.2010-0329OC. PMC   3208616 . PMID   21441383.
  53. Belding ME, Klebanoff SJ, Ray CG (January 1970). "Peroxidase-mediated virucidal systems". Science. 167 (3915): 195–6. Bibcode:1970Sci...167..195B. doi:10.1126/science.167.3915.195. PMID   4311694. S2CID   24040241.
  54. Tenovuo JO (1985). "Biochemistry of Peroxidase System: Antimicrobial Effects". In Tenovuo JO, Pruitt KM (eds.). The Lactoperoxidase system: chemistry and biological significance. New York: Dekker. p. 272. ISBN   978-0-8247-7298-7.
  55. Haukioja A, Ihalin R, Loimaranta V, Lenander M, Tenovuo J (September 2004). "Sensitivity of Helicobacter pylori to an innate defence mechanism, the lactoperoxidase system, in buffer and in human whole saliva". Journal of Medical Microbiology. 53 (Pt 9): 855–860. doi: 10.1099/jmm.0.45548-0 . PMID   15314191.
  56. Thomas EL, Milligan TW, Joyner RE, Jefferson MM (February 1994). "Antibacterial activity of hydrogen peroxide and the lactoperoxidase-hydrogen peroxide-thiocyanate system against oral streptococci". Infection and Immunity. 62 (2): 529–35. doi:10.1128/IAI.62.2.529-535.1994. PMC   186138 . PMID   8300211.
  57. Løvstad RA (December 2006). "A kinetic study on the lactoperoxidase catalyzed oxidation of estrogens". Biometals. 19 (6): 587–92. doi:10.1007/s10534-006-0002-3. PMID   16944280. S2CID   19254664.
  58. Gorlewska-Roberts KM, Teitel CH, Lay JO, Roberts DW, Kadlubar FF (December 2004). "Lactoperoxidase-catalyzed activation of carcinogenic aromatic and heterocyclic amines". Chemical Research in Toxicology. 17 (12): 1659–66. doi:10.1021/tx049787n. PMID   15606142.
  59. Hugoson A, Koch G, Thilander H, Hoogendoorn H (1974). "Lactoperoxidase in the prevention of plaque accumulation, gingivitis and dental caries. 3. Effect of mouthrinses with amyloglucosidase and glucoseoxidase in the model system of experimental gingivitis and caries in man". Odontologisk Revy. 25 (1): 69–80. PMID   4522423.
  60. Midda M, Cooksey MW (November 1986). "Clinical uses of an enzyme-containing dentifrice". Journal of Clinical Periodontology. 13 (10): 950–6. doi:10.1111/j.1600-051x.1986.tb01433.x. PMID   3098804.
  61. Hannig C, Spitzmüller B, Lux HC, Altenburger M, Al-Ahmad A, Hannig M (July 2010). "Efficacy of enzymatic toothpastes for immobilisation of protective enzymes in the in situ pellicle". Archives of Oral Biology. 55 (7): 463–9. doi:10.1016/j.archoralbio.2010.03.020. PMID   20417500.
  62. 1 2 Hannig C, Hannig M, Attin T (February 2005). "Enzymes in the acquired enamel pellicle". European Journal of Oral Sciences. 113 (1): 2–13. doi:10.1111/j.1600-0722.2004.00180.x. PMID   15693823.
  63. Jyoti S, Shashikiran ND, Reddy VV (2009). "Effect of lactoperoxidase system containing toothpaste on cariogenic bacteria in children with early childhood caries". The Journal of Clinical Pediatric Dentistry. 33 (4): 299–303. doi:10.17796/jcpd.33.4.83331867x68w120n. PMID   19725235.
  64. van Steenberghe D, Van den Eynde E, Jacobs R, Quirynen M (April 1994). "Effect of a lactoperoxidase containing toothpaste in radiation-induced xerostomia". International Dental Journal. 44 (2): 133–8. PMID   8063434.
  65. Kirstilä V, Lenander-Lumikari M, Tenovuo J (December 1994). "Effects of a lactoperoxidase-system-containing toothpaste on dental plaque and whole saliva in vivo". Acta Odontologica Scandinavica. 52 (6): 346–53. doi:10.3109/00016359409029032. PMID   7887144.
  66. Marino R, Torretta S, Capaccio P, Pignataro L, Spadari F (September 2010). "Different therapeutic strategies for burning mouth syndrome: preliminary data". Journal of Oral Pathology & Medicine. 39 (8): 611–6. doi:10.1111/j.1600-0714.2010.00922.x. PMID   20701667.
  67. Shin K, Yaegaki K, Murata T, Ii H, Tanaka T, Aoyama I, et al. (August 2011). "Effects of a composition containing lactoferrin and lactoperoxidase on oral malodor and salivary bacteria: a randomized, double-blind, crossover, placebo-controlled clinical trial". Clinical Oral Investigations. 15 (4): 485–93. doi:10.1007/s00784-010-0422-x. PMID   20512389. S2CID   21991883.
  68. Gil-Montoya JA, Guardia-López I, González-Moles MA (March 2008). "Evaluation of the clinical efficacy of a mouthwash and oral gel containing the antimicrobial proteins lactoperoxidase, lysozyme and lactoferrin in elderly patients with dry mouth--a pilot study". Gerodontology. 25 (1): 3–9. doi:10.1111/j.1741-2358.2007.00197.x. PMID   18194332.
  69. Nagy K, Urban E, Fazekas O, Thurzo L, Nagy E (September 2007). "Controlled study of lactoperoxidase gel on oral flora and saliva in irradiated patients with oral cancer". The Journal of Craniofacial Surgery. 18 (5): 1157–64. doi:10.1097/scs.0b013e3180de6311. PMID   17912104. S2CID   1253647.
  70. Shahdad SA, Taylor C, Barclay SC, Steen IN, Preshaw PM (September 2005). "A double-blind, crossover study of Biotène Oralbalance and BioXtra systems as salivary substitutes in patients with post-radiotherapy xerostomia". European Journal of Cancer Care. 14 (4): 319–26. doi: 10.1111/j.1365-2354.2005.00587.x . PMID   16098116.
  71. Matear DW, Barbaro J (January 2005). "Effectiveness of saliva substitute products in the treatment of dry mouth in the elderly: a pilot study". The Journal of the Royal Society for the Promotion of Health. 125 (1): 35–41. doi:10.1177/146642400512500113. PMID   15712851. S2CID   36508570.

Further reading